Cardiopulmonary involvement in Puumala hantavirus infection

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Rasmuson, Johan ^a   Lindqvist, Per ^a   Sörensen, Karen ^a   Hedström, Magnus ^a   Blomberg, Anders ^a   Ahlm, Clas ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Computed tomography; Echocardiography; Haemorrhagic fever with renal syndrome; Hantavirus; Natriuretic peptides; Respiratory function tests

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; TROPONIN T; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; AGED; ARTICLE; CARDIOPULMONARY HEMODYNAMICS; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; DISSEMINATED INTRAVASCULAR CLOTTING; DUODENAL ULCER BLEEDING; DYSPNEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HANTAVIRUS INFECTION; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE METABOLISM; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG ARTERY PRESSURE; LUNG DIFFUSION; LUNG EDEMA; LUNG FUNCTION TEST; LUNG VASCULAR RESISTANCE; MALE; PLEURA EFFUSION; PUUMALA HANTAVIRUS INFECTION; PUUMALA VIRUS; T WAVE; BLOOD; CASE CONTROL STUDY; HEART DISEASE; HEMORRHAGIC FEVER WITH RENAL SYNDROME; ISOLATION AND PURIFICATION; LUNG DISEASE; MIDDLE AGED; PATHOPHYSIOLOGY; RADIOGRAPHY; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASES; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PULMONARY EDEMA; PUUMALA VIRUS; TROPONIN T; YOUNG ADULT;

EID: 84886124590     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-501     Document Type: Article

References (58)

1. Jonsson CB, Figueiredo LT, Vapalahti O. A global perspective on hantavirus ecology, epidemiology, and disease. Clin Microbiol Rev 2010, 23:412-441. 10.1128/CMR.00062-09, 2863364, 20375360.
2. Botten J, Mirowsky K, Ye C, Gottlieb K, Saavedra M, Ponce L, Hjelle B. Shedding and intracage transmission of Sin Nombre hantavirus in the deer mouse (Peromyscus maniculatus) model. J Virol 2002, 76:7587-7594. 10.1128/JVI.76.15.7587-7594.2002, 136373, 12097572.
3. Hardestam J, Karlsson M, Falk KI, Olsson G, Klingström J, Lundkvist T. Puumala hantavirus excretion kinetics in bank voles (Myodes glareolus). Emerg Infect Dis 2008, 14:1209-1215. 10.3201/eid1408.080221, 2600398, 18680643.
4. Duchin JS, Koster FT, Peters CJ, Simpson GL, Tempest B, Zaki SR, Ksiazek TG, Rollin PE, Nichol S, Umland ET, et al. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group. N Engl J Med 1994, 330:949-955. 10.1056/NEJM199404073301401, 8121458.
5. Hallin GW, Simpson SQ, Crowell RE, James DS, Koster FT, Mertz GJ, Levy H. Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med 1996, 24:252-258. 10.1097/00003246-199602000-00012, 8605797.
6. Castillo C, Naranjo J, Sepulveda A, Ossa G, Levy H. Hantavirus pulmonary syndrome due to Andes virus in Temuco, Chile: clinical experience with 16 adults. Chest 2001, 120:548-554. 10.1378/chest.120.2.548, 11502657.
7. Vapalahti O, Mustonen J, Lundkvist T, Henttonen H, Plyusnin A, Vaheri A. Hantavirus infections in Europe. Lancet Infect Dis 2003, 3:653-661. 10.1016/S1473-3099(03)00774-6, 14522264.
8. Clement J, Colson P, McKenna P. Hantavirus pulmonary syndrome in New England and Europe. N Engl J Med 1994, 331:545-546.
9. Linderholm M, Sandström T, Rinnström O, Groth S, Blomberg A, Tärnvik A. Impaired pulmonary function in patients with hemorrhagic fever with renal syndrome. Clin Infect Dis 1997, 25:1084-1089. 10.1086/516093, 9402362.
10. Seitsonen E, Hynninen M, Kolho E, Kallio-Kokko H, Pettilä V. Corticosteroids combined with continuous veno-venous hemodiafiltration for treatment of hantavirus pulmonary syndrome caused by Puumala virus infection. Eur J Clin Microbiol Infect Dis 2006, 25:261-266. 10.1007/s10096-006-0117-z, 16550348.
11. Rasmuson J, Andersson C, Norrman E, Haney M, Evander M, Ahlm C. Time to revise the paradigm of hantavirus syndromes? Hantavirus pulmonary syndrome caused by European hantavirus. Eur J Clin Microbiol Infect Dis 2011, 30:685-690. 10.1007/s10096-010-1141-6, 3075397, 21234633.
12. Rasmuson J, Pourazar J, Linderholm M, Sandström T, Blomberg A, Ahlm C. Presence of activated airway T lymphocytes in human puumala hantavirus disease. Chest 2011, 140:715-722. 10.1378/chest.10-2791, 21436245.
13. Linderholm M, Billström A, Settergren B, Tärnvik A. Pulmonary involvement in nephropathia epidemica as demonstrated by computed tomography. Infection 1992, 20:263-266. 10.1007/BF01710791, 1358824.
14. Paakkala A, Järvenpää R, Mäkelä S, Huhtala H, Mustonen J. Pulmonary high-resolution computed tomography findings in nephropathia epidemica. Eur J Radiol 2012, 81:1707-1711. 10.1016/j.ejrad.2011.04.049, 21600717.
15. Linderholm M, Bjermer L, Juto P, Roos G, Sandström T, Settergren B, Tärnvik A. Local host response in the lower respiratory tract in nephropathia epidemica. Scand J Infect Dis 1993, 25:639-646. 10.3109/00365549309008554, 7904380.
16. Nolte KB, Feddersen RM, Foucar K, Zaki SR, Koster FT, Madar D, Merlin TL, McFeeley PJ, Umland ET, Zumwalt RE. Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Hum Pathol 1995, 26:110-120. 10.1016/0046-8177(95)90123-X, 7821907.
17. Zaki SR, Greer PW, Coffield LM, Goldsmith CS, Nolte KB, Foucar K, Feddersen RM, Zumwalt RE, Miller GL, Khan AS, et al. Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am J Pathol 1995, 146:552-579. 1869168, 7887439.
18. Puljiz I, Kuzman I, Markotic A, Turcinov D, Matic M, Makek N. Electrocardiographic changes in patients with haemorrhagic fever with renal syndrome. Scand J Infect Dis 2005, 37:594-598. 10.1080/00365540510036606, 16138429.
19. Mäkelä S, Kokkonen L, Ala-Houhala I, Groundstroem K, Harmoinen A, Huhtala H, Hurme M, Paakkala A, Pörsti I, Virtanen V, et al. More than half of the patients with acute Puumala hantavirus infection have abnormal cardiac findings. Scand J Infect Dis 2009, 41:57-62. 10.1080/00365540802502629, 18932105.
20. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, et al. Standardisation of spirometry. Eur Respir J 2005, 26:319-338. 10.1183/09031936.05.00034805, 16055882.
21. Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005, 26:720-735. 10.1183/09031936.05.00034905, 16204605.
22. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993, 16:5-40.
23. Cotes JE, Chinn DJ, Quanjer PH, Roca J, Yernault JC. Standardization of the measurement of transfer factor (diffusing capacity). Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993, 16:41-52.
24. Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002, 15:167-184. 10.1067/mje.2002.120202, 11836492.
25. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978, 58:1072-1083. 10.1161/01.CIR.58.6.1072, 709763.
26. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005, 18:1440-1463. 10.1016/j.echo.2005.10.005, 16376782.
27. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelisa A. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 2009, 10:165-193.
28. Chemla D, Castelain V, Humbert M, Hebert JL, Simonneau G, Lecarpentier Y, Herve P. New formula for predicting mean pulmonary artery pressure using systolic pulmonary artery pressure. Chest 2004, 126:1313-1317. 10.1378/chest.126.4.1313, 15486398.
29. Lindqvist P, Söderberg S, Gonzalez MC, Tossavainen E, Henein MY. Echocardiography based estimation of pulmonary vascular resistance in patients with pulmonary hypertension: a simultaneous Doppler echocardiography and cardiac catheterization study. Eur J Echocardiogr 2011, 12:961-966. 10.1093/ejechocard/jer222, 22011836.
30. Wahl A, Praz F, Schwerzmann M, Bonel H, Koestner SC, Hullin R, Schmid JP, Stuber T, Delacretaz E, Hess OM, et al. Assessment of right ventricular systolic function: comparison between cardiac magnetic resonance derived ejection fraction and pulsed-wave tissue Doppler imaging of the tricuspid annulus. Int J Cardiol 2011, 151:58-62. 10.1016/j.ijcard.2010.04.089, 20537415.
31. Tossavainen E, Söderberg S, Grönlund C, Gonzalez M, Henein MY, Lindqvist P. Pulmonary artery acceleration time in identifying pulmonary hypertension patients with raised pulmonary vascular resistance. Eur Heart J Cardiovasc Imaging in press.
32. Lindqvist P, Waldenström A, Wikström G, Kazzam E. Right ventricular myocardial isovolumic relaxation time and pulmonary pressure. Clin Physiol Funct Imaging 2006, 26:1-8. 10.1111/j.1475-097X.2005.00639.x, 16398663.
33. Henein M, Zhao Y, Henein MY, Lindqvist P. Disturbed left atrial mechanical function in paroxysmal atrial fibrillation: a speckle tracking study. Int J Cardiol 2012, 155:437-441. 10.1016/j.ijcard.2011.10.007, 22088228.
34. Lindqvist P, Zhao Y, Bajraktari G, Holmgren A, Henein MY. Aortic valve replacement normalizes left ventricular twist function. Interact Cardiovasc Thorac Surg 2011, 12:701-706. 10.1510/icvts.2010.262303, 21303867.
35. Sundberg E, Hultdin J, Nilsson S, Ahlm C. Evidence of disseminated intravascular coagulation in a hemorrhagic fever with renal syndrome-scoring models and severe illness. PLoS One 2011, 6:e21134. 10.1371/journal.pone.0021134, 3121717, 21731657.
36. Zapol WM, Snider MT. Pulmonary hypertension in severe acute respiratory failure. N Engl J Med 1977, 296:476-480. 10.1056/NEJM197703032960903, 834225.
37. Mackow ER, Gavrilovskaya IN. Hantavirus regulation of endothelial cell functions. Thromb Haemost 2009, 102:1030-1041.
38. Geimonen E, Neff S, Raymond T, Kocer SS, Gavrilovskaya IN, Mackow ER. Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses. Proc Natl Acad Sci U S A 2002, 99:13837-13842. 10.1073/pnas.192298899, 129784, 12368479.
39. Hayasaka D, Maeda K, Ennis FA, Terajima M. Increased permeability of human endothelial cell line EA.hy926 induced by hantavirus-specific cytotoxic T lymphocytes. Virus Res 2007, 123:120-127. 10.1016/j.virusres.2006.08.006, 16979772.
40. Shrivastava-Ranjan P, Rollin PE, Spiropoulou CF. Andes virus disrupts the endothelial cell barrier by induction of vascular endothelial growth factor and downregulation of VE-cadherin. J Virol 2010, 84:11227-11234. 10.1128/JVI.01405-10, 2953207, 20810734.
41. Hassoun PM, Mouthon L, Barbera JA, Eddahibi S, Flores SC, Grimminger F, Jones PL, Maitland ML, Michelakis ED, Morrell NW, et al. Inflammation, growth factors, and pulmonary vascular remodeling. J Am Coll Cardiol 2009, 54(1 Suppl):S10-19.
42. Laine O, Mäkelä S, Mustonen J, Huhtala H, Szanto T, Vaheri A, Lassila R, Joutsi-Korhonen L. Enhanced thrombin formation and fibrinolysis during acute Puumala hantavirus infection. Thromb Res 2010, 126:154-158. 10.1016/j.thromres.2010.05.025, 20579693.
43. Young JD. The heart and circulation in severe sepsis. Br J Anaesth 2004, 93:114-120. 10.1093/bja/aeh171, 15121730.
44. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992, 257:387-389. 10.1126/science.1631560, 1631560.
45. Hartemink KJ, Groeneveld AB. The hemodynamics of human septic shock relate to circulating innate immunity factors. Immunol Invest 2010, 39:849-862. 10.3109/08820139.2010.502949, 20718660.
46. Linderholm M, Groeneveld PH, Tärnvik A. Increased production of nitric oxide in patients with hemorrhagic fever with renal syndrome - relation to arterial hypotension and tumor necrosis factor. Infection 1996, 24:337-340. 10.1007/BF01716075, 8923042.
47. Saggioro FP, Rossi MA, Duarte MI, Martin CC, Alves VA, Moreli ML, Figueiredo LT, Moreira JE, Borges AA, Neder L. Hantavirus infection induces a typical myocarditis that may be responsible for myocardial depression and shock in hantavirus pulmonary syndrome. J Infect Dis 2007, 195:1541-1549. 10.1086/513874, 17436235.
48. Woods RL. Cardioprotective functions of atrial natriuretic peptide and B-type natriuretic peptide: a brief review. Clin Exp Pharmacol Physiol 2004, 31:791-794. 10.1111/j.0305-1870.2004.04073.x, 15566395.
49. Kim HN, Januzzi JL. Natriuretic peptide testing in heart failure. Circulation 2011, 123:2015-2019. 10.1161/CIRCULATIONAHA.110.979500, 21555724.
50. Witthaut R, Busch C, Fraunberger P, Walli A, Seidel D, Pilz G, Stuttmann R, Speichermann N, Verner L, Werdan K. Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med 2003, 29:1696-1702. 10.1007/s00134-003-1910-0, 12915939.
51. Bar SL, Swiggum E, Straatman L, Ignaszewski A. Nonheart failure-associated elevation of amino terminal pro-brain natriuretic peptide in the setting of sepsis. Can J Cardiol 2006, 22:263-266. 10.1016/S0828-282X(06)70908-4, 2528926, 16520860.
52. Shor R, Rozenman Y, Bolshinsky A, Harpaz D, Tilis Y, Matas Z, Fux A, Boaz M, Halabe A. BNP in septic patients without systolic myocardial dysfunction. Eur J Intern Med 2006, 17:536-540. 10.1016/j.ejim.2006.07.013, 17142170.
53. Hartemink KJ, Twisk JW, Groeneveld AB. High circulating N-terminal pro-B-type natriuretic peptide is associated with greater systolic cardiac dysfunction and nonresponsiveness to fluids in septic vs nonseptic critically ill patients. J Crit Care 2011, 26. 108 e1-8.
54. Bar SL, Sayeh N, Ignaszewski AP. Elevated N-terminal pro-brain natriuretic peptide in Mycobacterium tuberculosis pulmonary infection without myocardial dysfunction. Can J Cardiol 2009, 25:223-225. 10.1016/S0828-282X(09)70066-2, 2706760, 19340346.
55. Antonelli A, Ferri C, Ferrari SM, Marchi S, De Bortoli N, Sansonno D, Chiavacci C, Ferrannini E, Fallahi P. N-terminal pro-brain natriuretic peptide and tumor necrosis factor-alpha both are increased in patients with Hepatitis C. J Interferon Cytokine Res 2010, 30:359-363. 10.1089/jir.2009.0059, 20187770.
56. Schou M, Dalsgaard MK, Clemmesen O, Dawson EA, Yoshiga CC, Nielsen HB, Gustafsson F, Hildebrandt PR, Secher NH. Kidneys extract BNP and NT-proBNP in healthy young men. J Appl Physiol 2005, 99:1676-1680. 10.1152/japplphysiol.00641.2005, 16037399.
57. van Kimmenade RR, Januzzi JL, Bakker JA, Houben AJ, Rennenberg R, Kroon AA, Crijns HJ, van Dieijen-Visser MP, de Leeuw PW, Pinto YM. Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects. J Am Coll Cardiol 2009, 53:884-890. 10.1016/j.jacc.2008.11.032, 19264247.
58. Fijalkowska A, Kurzyna M, Torbicki A, Szewczyk G, Florczyk M, Pruszczyk P, Szturmowicz M. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. Chest 2006, 129:1313-1321. 10.1378/chest.129.5.1313, 16685024.